Also known as آسٹیوپوروسس مینجمنٹ
Endocrinologist
F.C.P.S (Medicine), F.C.P.S (Endocrine), MRCP (UK)
Endocrinologist
F.C.P.S (Medicine), F.C.P.S (Endocrine), MRCP (UK)
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, MRCP (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterologist)
Endocrinologist
M.B.B.S., MSc., P.E.C
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology), SCE Endocrinology and Diabetes
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology), SCE Endocrinology and Diabetes
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, MS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures